Abstract

Unwarranted variation of coronary stent choice in The Netherlands.

Highlights

  • Journal, a study by Burgers et al [3] investigated the treatment variation in stent choice (BMS vs. drug-eluting stents (DES)) in patients with stable and unstable coronary artery disease (CAD) across 4 medical centres in the Netherlands

  • This study is a sub-analysis of the CIRCULATING CELLS study that included patients from March 2009 until September 2011 and aimed to discover markers to predict future cardiovascular events

  • 66 % of 442 patients were treated with DES with no difference of DES use between stable (n = 358) or unstable CAD patients (n = 84)

Read more

Summary

Introduction

A study by Burgers et al [3] investigated the treatment variation in stent choice (BMS vs. DES) in patients with stable and unstable CAD across 4 medical centres in the Netherlands. 66 % of 442 patients were treated with DES with no difference of DES use between stable (n = 358) or unstable CAD patients (n = 84). Increased use of DES was associated with NYHA class, smoking, multivessel disease, previous PCI, diabetes mellitus, and interestingly treating hospital which explained 33 % of the variation in stent choice. DES use in patients varied widely between hospitals, ranging from 50 to 99 %.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call